GUANGJI PHARMA.(SZ:000952) Xin Lang Cai Jing·2026-01-27 06:15Group 1 - Guangji Pharmaceutical's stock price increased by 5.01% on January 27, reaching 8.18 yuan per share, with a trading volume of 235 million yuan and a turnover rate of 8.98%, resulting in a total market capitalization of 2.836 billion yuan [1] - The stock has risen for three consecutive days, with a cumulative increase of 4.7% during this period [1] - Guangji Pharmaceutical, established on May 28, 1993, and listed on November 12, 1999, is based in Wuhan, Hubei Province, and primarily engages in the production and sale of pharmaceutical raw materials, veterinary raw materials, feed additives, and fine chemical products [1] Group 2 - The top ten circulating shareholders of Guangji Pharmaceutical include a fund from Huaxia Fund, specifically the Huaxia CSI 500 Index Enhanced A (007994), which newly entered the top ten shareholders in the third quarter, holding 2.2814 million shares, accounting for 0.66% of circulating shares [2] - The fund has generated an estimated floating profit of approximately 889,800 yuan today and 798,500 yuan during the three-day increase [2] - The Huaxia CSI 500 Index Enhanced A fund was established on March 25, 2020, with a latest scale of 3.37 billion yuan, and has achieved a year-to-date return of 10.75% and a one-year return of 48.88% [2]